News

oncNGS PCP - European Call for tender for the future Next Generation Sequencing (NGS) solutions for cancer

Published on | 3 years ago

Programmes Health

The aim of the oncNGS pre-commercial procurement (PCP) is to develop affordable integrated solutions that can completely transform cancer patients' experience through predictive diagnosis, prognosis and theranosis capabilities based on Next Generation Sequencing (NGS) technology. OncNGS invites entrepreneurs, start-ups, companies, academia, and other relevant stakeholders to present their proposal for designing, developing and testing their solution that will be provided during this PCP.

The oncNGS PCP Call for tender is now open. Deadline for submission is 17 October 2022.

  • The contract notice of the Pre-commercial procurement has been published at Tenders Electronic Daily here.
  • The complete tender documentation is available here.
  • Bidders can participate in a joint tender and look for suitable partners through oncNGS' matchmaking page.
  • A Frequently Asked Questions page is also available on the oncNGS website.

All detailed information can be found on oncNGS' website.

 

Background information: The Horizon 2020 financed project 'OncNGS'  is a strong consortium composed of 8 buyers from 5 EU Member States (Sciensano ; Institut Jules Bordet (Belgium) ; Institut Curie ; Hospices Civils de Lyon (France) ; Charite Universitaetsmedizin ; Ludwig Maximilians Universitaet Muenchen (Germany) ; Alleanza Contro il Cancro (Italy) ; Institut Catala d’Oncologia (Spain)) and supported by 6 entities with wide experience in their fields (Agència de Qualitat i Avaluació Sanitàries de Catalunya ; the Belgian Cancer Registry ; Institut National du Cancer ; Instituto de Investigación Biomédica de Salamanca ; Valle de Hebrón Instituto de Oncología ; De Clercq & Partners). 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1773 articles available search in articles 

Testimonial

ScreenME - Enhancing excellence in screen media entrepreneurship

The Horizon2020 twinning project ScreenME has as its objective to enhance excellence in screen media entrepreneurship at Tallinn University (TLU). To do so, ScreenME has established a network of universities across Europe that aim to improve research into and teaching of entrepreneurship for the screen media industry. ScreenME will develop a teaching course and will kick off research initiatives and projects on entrepreneurial activities in media organisations. The research group on ‘Studies in Media, Innovation and Technology (SMIT)’ of the Vrije Universiteit Brussel (VUB) is partner in the network and is involved in two cross-cutting activities of the project: support for early stage researchers and developing stakeholder involvement.